Hatva, E. et al., “Expression of Endothelial Cell-Specific Receptor Tyrosine Kinases and Growth Factors in Human Brain Tumors,” Amer. Journal of Pathology, vol. 146, No. 2, pp. 368-378 (Feb. 1995). |
Lempert-Sreter, M. et al., “Electron deficient heteroaromatic ammonioamidates,” Chem. Abstract, vol. 93, entry 150203, 1 page (1980). |
Miyashtai, A. et al., “Catalytic Action of Azolium Salts. II.1 )Aroylation of 4-Chloroquinazolines with Aromatic Aldehydes Catalyzed by 1,3-Dimethylbenzimidazolium Iodide,” Chem. Pharm, Bull.vol. 40, No. 1, pp. 43-48 (Jan. 1992). |
Miyashita, A. et al., “An Approach to the Synthesis of a Papaverine Analogue Containing Quinazoline Ring System,” Heterocycles,vol. 40, No. 2 pp. 653-660 (1995). |
Miyashita, A. et al., “Several approaches to cyanide ion-catalyzed synthesis of 4-aroyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidines,” Chem. Abstract., vol. 128, entry 270579, 1 page (1998). |
Myers, M. R. et al., “The Preparation and SAR of 4-(Anilino), 4-(Phenoxy), and 4-(Thiopenoxy)-Quinazolines: Inhibitors of p56lck and EGF-R Tyrosine Kinase Activity,” Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 4, pp. 417-420 (1997). |
Narla, R. K. et al., “4-(3′-Bromo-4′hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: A Novel Quinazoline Derivative with Potent Cytotoxic Activity against Human Glioblastoma Cells,” Clinical Cancer Reserach, vol. 4, pp. 1405-1414 (Jun. 1998). |
Narla, R. K. et al., Inhibition of Human Glioblastoma Cell Adhesion and Invasion by 4-(4′-Hydroxylphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P131) and 4-(3′Bromo-4′-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P154), Clinical Cancer Research, vol. 4, NO. 10, pp. 2463-2471 (Oct. 1998). |
Nomoto, Y. et al., “Studies on Cardiotonic Agents. I. Synthesis of Some Derivatives,” Chem. Pharm. Bull., vol. 38, No. 6, pp. 1591-1595 (1990). |
Suzuki, Y. et al., “Carbon-carbon bond cleavage of .alpha.-hydroxvbenzylheteroarenes catalyzed,” Chem. Abstract, vol. 128, entry 230337, 5 pages (1998). |
Taylor, E. C. et al., “General procedure for the synthesis of epoxyalkylated and acylated heterocycles,” Chem. Abstract. vol. 93, entry 47718, 2 pages (1974). |
Zagzag, D. “Angiogenic Growth Factors in Neural Embryogenesis and Neoplasia,” Amer. Journal of Pathology, vol. 146, No. 2, pp. 293-309 (Feb. 1995). |
Bridges, A. et al., “Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure-Activity Relationship for Analogues of 4-(3-Bromoanliino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth Factor Receptor”, Journal of Medicinal Chemistry, vol. 39, pp. 267-276 (Jan. 9, 1996). |
Budesinsky, Z. et al., “A New Synthesis of the Quinazoline Nucleus”, Collection of Czechoslovak Chemical Communications, vol. 37, No. 8, pp. 2779-2785 (Aug. 1972). |
Fetter, J. et al. “Election Deficient Heteroaromatic Ammonioamidates-XVIa , The Synthesis and Photochemistry of Ethyl N-(2-Methyl-4-Methylene-6,7-Methylenedioxy-3,4-Dihydro-3-Quinazolinyl)-N-Phenylcarbamate”, Tetrahedron, vol. 34, pp. 2557-2563 (1978). |
Goodman, P. et al., “Role of Tyrosine Kinases in Induction of the c-jun Proto-oncogene in Irradiated B-lineage Lymphoid Cells”, The Journal of Biological Chemistry, vol. 273, No. 28, pp. 17742-17748 (Jul. 10, 1998). |
Higashino, T. et al., “Reactions of the anion of quinazoline Reissert compound (3-benzoyl-3,4-dihydro-4-quinazolinecarbon itrile) with electrophiles”, Chemical & Pharamaceutical Bulletin,vol. 33, No. 3, pp. 950-961 (Mar. 1985). |
Ife, R. et al., “Reversible Inhibitors of Gastric (H+/K+)-ATPase”, Journal of Medicinal Chemistry, vol. 38, No. 14, pp. 2763-2773 (Jul. 7, 1995). |
Kubo, K. et al., “Novel Series of 4-Phenoxyquinolines: Potent and Highly Selective Inhibitors of PDGF Receptor Autophosphorylation”, Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 23, pp. 2935-1940 (Dec. 2, 1997). |
Malaviya, R et al., “Genetic and Biochemical Evidence for a Critical Role of Janus Kinase (JAK)-3 in Mast Cell-Mediated Tyoe I Hypersensitivity Reactions”, Biochemical and Biophysical Research Communications, vol. 257, No. 3, pp. 807-813 (Apr. 21, 1999). |
Myers, M. et al. “The preparation and SAR of 4-(anilino), 4-(phenoxy), and 4-(thiophenoxy)-quinazolines: inhibitors of p56lck and EGF-R tyrosine kinase activity”, Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 4, pp. 417-420 (1997). |